Costica Aloman to Humans
This is a "connection" page, showing publications Costica Aloman has written about Humans.
Connection Strength
0.317
-
Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. Hepatol Commun. 2022 11; 6(11):3247-3259.
Score: 0.045
-
Recipient risk factors for acute cellular rejection after orthotopic liver transplant - a single-center, retrospective study. Transpl Int. 2020 12; 33(12):1779-1787.
Score: 0.039
-
Restricted immunological and cellular pathways are shared by murine models of chronic alcohol consumption. Sci Rep. 2020 02 12; 10(1):2451.
Score: 0.037
-
Dendritic cells and liver fibrosis. Biochim Biophys Acta. 2013 Jul; 1832(7):998-1004.
Score: 0.023
-
Dendritic cells in alcoholic liver injury and fibrosis. Alcohol Clin Exp Res. 2011 May; 35(5):776-81.
Score: 0.020
-
Hepatic fibrosis. Curr Opin Gastroenterol. 2009 May; 25(3):223-9.
Score: 0.018
-
Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes. J Clin Gastroenterol. 2024 Jan 01; 58(1):91-97.
Score: 0.012
-
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int. 2022 03; 42(3):607-614.
Score: 0.011
-
Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease. Am J Gastroenterol. 2021 10 01; 116(10):2089-2097.
Score: 0.010
-
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Hepatology. 2021 06; 73(6):2099-2109.
Score: 0.010
-
A subset of liver resident natural killer cells is expanded in hepatitis C-infected patients with better liver function. Sci Rep. 2021 01 15; 11(1):1551.
Score: 0.010
-
Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience. Hepatology. 2020 12; 72(6):1900-1911.
Score: 0.010
-
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2021 03; 74(3):567-577.
Score: 0.010
-
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2021 Jul; 19(7):1469-1479.e19.
Score: 0.010
-
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol. 2020 11; 5(11):1008-1016.
Score: 0.010
-
Individual liver plasmacytoid dendritic cells are capable of producing IFNa and multiple additional cytokines during chronic HCV infection. PLoS Pathog. 2019 07; 15(7):e1007935.
Score: 0.009
-
Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantation. Clin Transplant. 2016 06; 30(6):722-30.
Score: 0.007
-
The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients. Clin Transplant. 2016 Mar; 30(3):241-6.
Score: 0.007
-
Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest. 2013 Aug; 123(8):3510-24.
Score: 0.006
-
Generation and characterization of an immunogenic dendritic cell population. J Immunol Methods. 2008 Mar 20; 332(1-2):18-30.
Score: 0.004
-
Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity. Alcohol Clin Exp Res. 2006 Apr; 30(4):709-19.
Score: 0.004
-
Antibody-directed therapy for human hepatocellular carcinoma. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S225-31.
Score: 0.003
-
Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co-expressing HCV core protein and CYP2E1. J Med Virol. 2004 Feb; 72(2):230-40.
Score: 0.003